Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: An updated analysis

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 5033-5042

  Xue, Hong ^a   Su, Jian ^b   Sun, Kai ^a   Xie, Weiping ^a   Wang, Hong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

COPD; Gene polymorphism; Glutathione S transferase; Meta analysis

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ADULT; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUTATHIONE TRANSFERASE M1 GENE; GLUTATHIONE TRANSFERASE T1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SMOKING; ARTICLE; CONFIDENCE INTERVAL; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PUBLISHING; RISK;

ASIAN CONTINENTAL ANCESTRY GROUP; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PUBLICATION BIAS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 84863100389     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1300-6     Document Type: Review

References (34)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163:1256-1276
2. Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532-555
3. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC (2002) Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ 51:1-16
4. Molfino NA (2004) Genetics of COPD. Chest 125:1929-1940
5. Strange RC, Spiteri MA, Ramachandran S, Fryer AA (2001) Glutathione-S-Transferase family of enzymes. Mutat Res 482:21-26
6. Benhamou S, Lee WJ, Alexandrie AK et al (2002) Meta-and pooled analyses of the effects of glutathione S-Transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 23:1343-1350
7. Lakhdar R, Denden S, Mouhamed MH, et al (2011) Correlation of EPHX1, GSTP1, GSTM1, and GSTT1 genetic polymorphisms with antioxidative stress markers in chronic obstructive pulmonary disease. Exp Lung Res 37(4):195-204
8. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-Analysis detected bya simple, graphical test.BMJ315:629-634
9. Budhi A, Hiyama K, Isobe T et al (2003) Genetic susceptibility for emphysematous changes of the lung in Japanese. Int J Mol Med 11:321-329
10. Yim JJ, Park GY, Lee CT et al (2000) Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-Transferase M1 and T1. Thorax 55:121-125
11. Chan-Yeung M, Ho SP, Cheung AH et al (2007) Polymorphisms of glutathione S-Transferase genes and functional activity in smokers with or without COPD. Int J Tuberc Lung Dis 11:508-514
12. Calikoglu M, Tamer L, Ates Aras N, Karakas S, Ercan B (2006) The association between polymorphic genotypes of glutathione S-Transferases and COPD in the Turkish population. Biochem Genet 44:307-319
13. Cheng SL, Yu CJ, Chen CJ, Yang PC (2004) Genetic polymorphism of epoxide hydrolase and glutathione S-Transferase in COPD. Eur Respir J 23:818-824
14. Faramawy MM, Mohammed TO, Hossaini AM, Kashem RA, Abu Rahma RM (2009) Genetic polymorphism of GSTT1 and GSTM1 and susceptibility to chronic obstructive pulmonary disease (COPD). J Crit Care 24:e7-e10
15. Thakur H, Gupta L, Sobti RC, Janmeja AK, Seth A, Singh SK (2011) Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population. Mol Biol Rep 38: 1733-1739
16. Ma Zhi-Ming Zz-X, HAN Ze-Min et al (2004) A study on the correlation between the polymorphism or GSTM1 and GSTT1 and susceptibility to the development of COPD. Zhong Guo Yi Shi Za Zhi 6:721-724
17. Yang Ruihong HQ, Lu B, Zhang R (2004) Association of genetic polymorphism of glutathione S-Transferase M1 and T1 with susceptibility to chronic obstructive pulmonary disease. Chin J Respir Crit Care Med 3:79-82
18. Mehrotra S, Sharma A, Kumar S, Kar P, Sardana S, Sharma JK (2010) Polymorphism of glutathione S-Transferase M1 and T1 gene loci in COPD. Int J Immunogenet 37:263-267
19. Yanchina ED, Ivchik TV, Shvarts EI, Kokosov AN, Khodzhayantz NE (2004) Gene-gene interactions between glutathione-s transferase M1 and matrix metalloproteinase 9 in the formation of hereditary predisposition to chronic obstructive pulmonary disease. Bull Exp Biol Med 137:64-66
20. Baranova H, Perriot J, Albuisson E et al (1997) Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet 99:822-826
21. Hersh CP, Demeo DL, Lange C et al (2005) Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 33:71-78
22. Zidzik J, Slaba E, Joppa P et al (2008) Glutathione S-Transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population. Croat Med J 49:182-191
23. American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:S77-S121
24. COPD Branch in Chinese Thoracic Society (2002) The guideline of diagnosis and management for COPD. Chin J Tuberc Respir Dis 25:453-460
25. Celli BR, MacNee W (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:932-946
26. Burchfiel CM, Marcus EB, Curb JD et al (1995) Effects of smoking and smoking cessation on longitudinal decline in pulmonary function. Am J Respir Crit Care Med 151:1778-1785
27. Rahman I, Swarska E, Henry M, Stolk J, MacNee W (2000) Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 55:189-193
28. Sandford AJ, Silverman EK (2002) Chronic obstructive pulmonary disease. 1: susceptibility factors for COPD the genotype-environment interaction. Thorax 57:736-741
29. Hosgood HD III, Berndt SI, Lan Q (2007) GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-Analysis. Mutat Res 636:134-143
30. Harrison DJ, Cantlay AM, Rae F, Lamb D, Smith CA (1997) Frequency of glutathione S-Transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 16:356-360
31. Munafo M (2004) Replication validity of genetic association studies of smoking behavior: what can meta-Analytic techniques offer? Nicotine Tob Res 6:381-382
32. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG (2001) Replication validity of genetic association studies. Nat Genet 29:306-309
33. Eaton DL, Bammler TK (1999) Concise review of the glutathione S-Transferases and their significance to toxicology. Toxicol Sci 49:156-164
34. Hu G, Yao W, Zhou Y et al (2008) Meta-and pooled analyses of the effect of glutathione S-Transferase M1 and T1 deficiency on chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 12:1474-1481